CERS3: Ceramide Synthase 3

Key enzyme in de novo ceramide synthesis, essential for skin barrier function and spermatogenesis

Gene Information Card

Symbol CERS3
Full Name Ceramide Synthase 3
Gene Type Protein coding
Chromosomal Location 15q26.3
NCBI Gene ID 204219 ncbi.nlm.nih.gov/gene/204219
Ensembl ID ENSG00000154227
UniProt ID Q8IU89
OMIM ID 615276
HGNC ID 23752
Aliases LASS3, longevity assurance homolog 3

Description

CERS3 (ceramide synthase 3) encodes a member of the ceramide synthase family that catalyzes the synthesis of ceramides with very long-chain fatty acids (C26-C36). The enzyme is primarily expressed in skin, testis, and brain, playing a critical role in epidermal barrier formation and spermatogenesis. Mutations in CERS3 cause autosomal recessive congenital ichthyosis type 9 (ARCI9).

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Autosomal recessive congenital ichthyosis 9 (ARCI9) Loss-of-function mutations impair synthesis of very long-chain ceramides, disrupting epidermal lipid barrier OMIM #615276; multiple homozygous/compound heterozygous mutations reported in families
Non-syndromic ichthyosis Deficient CERS3 activity leads to abnormal stratum corneum lipid composition ClinVar; case studies

Expression Profile

Tissue Expression
Tissue nTPM level
Skin 12.8 Medium
Testis 8.5 Medium
Brain 3.2 Low
Lung 1.1 Not detected
Liver 0.5 Not detected
Cell Line Expression
Cell Line nTPM Notes
Keratinocytes 15.3 Primary human keratinocytes
Sertoli cells 9.7 Testicular cell line
SH-SY5Y 4.2 Neuroblastoma cell line
HeLa 0.8 Cervical carcinoma
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.748C>T (p.Arg250*) Nonsense Rare Loss of function; truncation of catalytic domain
c.1253G>A (p.Gly418Asp) Missense Rare Impaired enzyme activity; reduced ceramide synthesis
c.1039C>T (p.Arg347Trp) Missense Rare Decreased protein stability; associated with ARCI9
Mutation functional classification

Loss of Function (LOF)

Homozygous or compound heterozygous loss-of-function mutations (nonsense, frameshift, missense) cause autosomal recessive congenital ichthyosis 9 by abolishing very long-chain ceramide synthesis.

Gain of Function (GOF)

No gain-of-function mutations reported in CERS3.

Dominant Negative (DN)

No dominant-negative effects described; disease is recessive.

Gene Ontology (GO)

transferase activity (GO:0016747) • sphingosine N-acyltransferase activity (GO:0017084)
ceramide metabolic process (GO:0006672) sphingolipid biosynthetic process (GO:0030148)
endoplasmic reticulum (GO:0005783) • integral component of membrane (GO:0016021)

Pathways

Ceramide de novo biosynthesis (Reactome: R-HSA-1660661)
Sphingolipid metabolism (KEGG: hsa00600)
Keratinocyte differentiation (Reactome: R-HSA-6805567)

Protein Summary

Ceramide synthase 3 (CERS3) is a 383-amino acid transmembrane protein localized to the endoplasmic reticulum. It catalyzes the acylation of sphingoid bases to form ceramides, specifically using very long-chain fatty acyl-CoAs (C26-C36). The enzyme is essential for the synthesis of epidermal ceramides that constitute the skin permeability barrier and for testicular sphingolipids required for spermatogenesis. CERS3 belongs to the longevity assurance (LASS) family and contains a conserved TLC (TRAM, LAG1, CLN8) domain.

Related Products

Product name Cat.No. Species Gene ID
CERS3 Knockout HEK293 Cell Line EDJ-KQ1735 Human 204219 Details Get a Quote
CERS3 Knockout HeLa Cell Line EDJ-KQ59052 Human 204219 Details Get a Quote
CERS3 Knockout A-549 Cell Line EDJ-KQ67529 Human 204219 Details Get a Quote
CERS3 Knockout HCT 116 Cell Line EDJ-KQ75926 Human 204219 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: